In addition, increased XPO1 is known to correlate with elevated prognostic markers in pancreatic cancer, such as serum CEA and CA19.9, so it is theoretically possible to use it in predicting poor PFS and OS. The gene discussed is XPO1; the disease is pancreatic neoplasm.